Practice Short cuts

Epirubicin improves classic chemotherapy for early breast cancer

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7576.1014-c (Published 09 November 2006) Cite this as: BMJ 2006;333:1014

Adjuvant chemotherapy reduces the risk of cancer recurrence and prolongs survival in women with early breast cancer. Traditional regimens of cyclophosphamide, methotrexate, and fluorouracil (CMF) have been around since the 1970s, but it's now clear that regimens including an anthracycline such as epirubicin work …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe